CLINDAMYCIN PHOSPHAT Pfizer 300 mg/2ml amp 2 ml
7680618980012
CH-61898
J01FF01
08.01.92
1 / 3
google
Details
- Product number
- 6189801
- CPT
- -
- Packaging group
- 1 x 2
- Unit
- ml
- Composition
- clindamycinum 300 mg ut clindamycini phosphas, dinatrii edetas, natrii hydroxidum q.s. ad pH, alcohol benzylicus 18 mg, aqua ad iniectabile ad solutionem pro 2 ml corresp. natrium 17.92 mg.
Articles (1)
Clindamycin Phosphat Pfizer i.v./i.m. 300 mg, Injektionslösung
Injektionslösung
1 x 2
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
18.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
17.92 MG | Substance | HBESI |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 61898
- Drug name
- Clindamycin Phosphat Pfizer i.v./i.m., Injektionslösung
- Galenic form
- LSPA
- ATC Code
- J01FF01
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- A
- First authorization
- 10/03/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.92
- Domain
- Human medicine
Packaging details
- Description (FR)
- CLINDAMYCIN PHOSPHAT Pfizer 300 mg/2ml amp 2 ml
- Description (DE)
- CLINDAMYCIN PHOSPHAT Pfizer 300 mg/2ml Amp 2 ml
- Market launch
- 10/03/2011
- Narcotic (BTM)
- No